ABVX

Abivax S.A.

Healthcare›Biotechnology|NASDAQ Global Market|FR

Price

$118.37

Market Cap

$7.76B

Beta

-0.10

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+19.25%

EPS Growth (YoY)+2.86%

Revenue CAGR 3Y+136.58%

P/E Ratio0.0

PEG Ratio—

FCF Yield-2.60%

Debt / Equity0.07

Interest Coverage-14.0x

No credit card required

Already have an account? Sign in to view the full analysis for ABVX.